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We report a very rare case of Sevoﬂurane Induced Diffuse Alveolar Hemorrhage in a previously healthy
young adult in the post-operative period following general anesthesia. Diffuse alveolar hemorrhage
(DAH) associated with inhalation injury from halogenated gases is a unique entity in the literature that
practicing clinicians should be cognizant of and considered in post-operative cases of acute respiratory
distress whereby other etiologies have been excluded.
© 2016 Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Diffuse alveolar hemorrhage (DAH) results from widespread
damage to the pulmonary small vessels, leading to blood collecting
within the alveoli. In this report, we describe a novel case of an
inhaled anesthetic, Sevoﬂurane, inducing pulmonary hemorrhage
in an otherwise healthy individual during a routine urological
procedure.
2. Clinical case
A 20-year-old manwas admitted for a urethral stricture dilation
via cystoscopy and retrograde urethrogram. He had a history of
exercise-induced asthma.
His preoperative anesthesia evaluation was unremarkable. In-
duction medications included intravenous propofol, fentanyl and
versed. The surgery was performed under general anesthesia using
inhaled sevoﬂurane.
The patient was successfully extubated following the surgery.
However, approximately one hour after the completion of the
procedure, he developed acute hypoxemic respiratory distress in
the post-anesthesia care unit requiring reintubation.
Postoperatively, the patient was afebrile, with heart rate 115
beats/min, BP of 95/50 mm Hg, respiratory rate of 22 breaths/min,
and an oxygen saturation of 91% on 35% 40 L/min via high ﬂowAlbany Medical College, 43
).
n open access article under the Cnasal cannula.
Chest examinationwas remarkable for coarse crackles that were
most prominent at the bases of the chest bilaterally. The remainder
of the examination was normal.
A hemogram demonstrated a leukocytosis (13.6  109/L), a
normal hemoglobin level (14.0 g/dL) and platelet count (157  109/
L). He had a normal serum creatinine (1.1 mg/dL). An echocardio-
gram demonstrated normal left ventricular function, and no
structural or valvular abnormalities.
Pre-procedure, chest radiography (CXR) was unremarkable;
however postoperatively, the CXR demonstrated patchy, peripheral
consolidations bilaterally, sparing the apices and bases (Fig. 1).
Computer tomography of the thorax revealed patchy bilateral lung
consolidation and ground glass opacities in an upper lobe pre-
dominant distribution (Fig. 2). Given high index of suspicion for
pulmonary hemorrhage, the patient underwent a diagnostic
bedside bronchoscopy, which demonstrated diffuse erythema
throughout the tracheobronchial tree. There was no evidence of
thermal airway injury. Sequential bronchoalveolar lavage of mul-
tiple lobes (anterior segment of the right and left upper lung lobes)
showed progressively bloody return consistent with diffuse alve-
olar hemorrhage.
Microbiological workup for bacterial, fungal and viral infections
were non-revealing. Extensive serological workup for vasculitides
was also negative.
The patient was managed conservatively with supportive care
and improved clinically with successful extubation in three days.
Follow up CXR at one month showed complete resolution of pul-
monary inﬁltrates.C BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. CXR PA View- Demonstrating Bilateral Alveolar Inﬁltrates without effusion.
Fig. 2. CT chest sagittal section- demonstrating bilateral, peripheral alveolar opacities.
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Sevoﬂurane is a commonly used volatile inhaled halogenated
gas for rapid induction during general anesthesia. The medication
has a rapid washout time in comparison to other agents in its class
due to its lower blood solubility and bloodegas partition coefﬁcient
[1].
Sevoﬂurane is metabolized directly by the two forms of alkaline
carbon dioxide absorbents in the circuits of anesthesia machines
producing toxic metabolites. The main metabolite is ﬂuoromethyl-
2,2-diﬂuoro-1-(triﬂuoromethyl) vinyl ether, referred to as Com-
pound A [2]. Compound A has been hypothesized to cause direct
renal toxicity in murine and human studies [3,4]. It is unclear if
Compound A causes pulmonary toxicity. However, pulmonary
endothelial damage associated with other halogenated gases has
been postulated in the literature. Volatile gases are lipid soluble andpotentiate the arachidonic cascade in the cell membrane [4]. As a
consequence, exposure can cause alveolar permeability, increased
oxidative stress and heightened inﬂammatory response [5]. Sevo-
ﬂurane may also activate a similar pathway in the appropriate
setting.
Several case studies reported instances of exothermic reactions
with sevoﬂurane and the carbon dioxide absorbents in the anes-
thesia circuits producing ﬁre resulting in thermal airway injuries
and acute respiratory distress syndrome from spontaneous com-
bustion [6,7]. Possibly, occult less severe thermal injuries may be
responsible for previous reports of pulmonary toxicity from Com-
pound A.
To date, only two cases have been reported describing the
development of pulmonary hemorrhage following sevoﬂurane
administration during general anesthesia [8,9]. Airway inspection
in the both reports did not demonstrate signs of thermal injury.
There was no evidence of an alternative cause of lung injury
including infectious, inﬂammatory or malignant etiologies. Treat-
ment in both cases was supportive and there was no recurrence of
pulmonary injury.
In conclusion, DAH from inhaled sevoﬂurane should be
considered in post-operative cases of acute respiratory distress and
pulmonary hemorrhage in which other etiologies have been
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